Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621020 · ClinicalTrials.gov registry record
Clinical Performance Evaluation of T-TAS 01 PL Chip
A clinical trial, sponsored by Hikari Dx.
- Completed
- Registry status
- 307
- Enrollment target
NCT03621020 is a clinical trial that has completed, run by Hikari Dx. The registered enrollment target is 307 participants.
The verdict
NCT03621020 has completed, sponsored by Hikari Dx.
- COMPLETED
- Registry status
- 307 participants
- Enrollment target
Study Summary
This study will measure primary hemostatic ability using the T-TAS 01 System with PL chip, with a comparison to clinical truth.
Interventions
- DIAGNOSTIC_TEST T-TAS 01 PL Chip
- DIAGNOSTIC_TEST PFA-100 Col/Epi and Col/ADP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2020-02-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621020
The ClinicalTrials.gov registry entry for NCT03621020 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 307 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hikari Dx, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which T-TAS 01 PL Chip is the first listed.
NCT03621020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03621020 about?
NCT03621020 is a clinical study titled "Clinical Performance Evaluation of T-TAS 01 PL Chip". This study will measure primary hemostatic ability using the T-TAS 01 System with PL chip, with a comparison to clinical truth.
What is the current status of trial NCT03621020?
This trial is currently completed. The enrollment target is 307 participants. The study started on 2018-09-01. Estimated completion is 2020-02-14.
What interventions are being tested in trial NCT03621020?
The interventions under investigation include: T-TAS 01 PL Chip (DIAGNOSTIC_TEST), PFA-100 Col/Epi and Col/ADP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03621020?
This trial is sponsored by Hikari Dx, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.